Related references
Note: Only part of the references are listed.Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease
Sang-Ho Choi et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Statins Reduce Amyloid β-Peptide Production by Modulating Amyloid Precursor Protein Maturation and Phosphorylation Through a Cholesterol-Independent Mechanism in Cultured Neurons
Ai Hosaka et al.
NEUROCHEMICAL RESEARCH (2013)
Cerebrovascular Effects of Apolipoprotein E Implications for Alzheimer Disease
Berislav V. Zlokovic
JAMA NEUROLOGY (2013)
Neurodegeneration as a consequence of failed mitochondrial maintenance
Mariusz Karbowski et al.
ACTA NEUROPATHOLOGICA (2012)
Alzheimer's Disease, Cerebrovascular Disease, and the β-amyloid Cascade
Kie Honjo et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
L. Szalardy et al.
CURRENT MEDICINAL CHEMISTRY (2012)
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
S. Sorbi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain
Dietmar Rudolf Thal et al.
EXPERIMENTAL GERONTOLOGY (2012)
Cerebral Hypoperfusion and Cognitive Impairment: The Pathogenic Role of Vascular Oxidative Stress
Hui Liu et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2012)
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
Fredrik Jeppsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Kynurenines and headache
Arpad Pardutz et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Involvement of kynurenines in Huntington's disease and stroke-induced brain damage
Trevor W. Stone et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Behavioural studies with a newly developed neuroprotective KYNA-amide
Levente Gellert et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Where does a migraine attack originate? In the brainstem
J. Tajti et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
The kynurenine pathway in neurodegenerative diseases: Mechanistic and therapeutic considerations
Lin Tan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Mechanism of Oxidative Stress in Neurodegeneration
Sonia Gandhi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Discovery of an Orally Available, Brain Penetrant BACE1 Inhibitor That Affords Robust CNS Aβ Reduction
Andrew W. Stamford et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
Serge Gauthier et al.
CANADIAN GERIATRICS JOURNAL (2012)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
Prevalence and incidence of dementia among 75-80-year-old community-dwelling elderly in different districts of Antwerp, Belgium: The Antwerp Cognition (ANCOG) Study
P. P. De Deyn et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2011)
The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
Susanna Campesan et al.
CURRENT BIOLOGY (2011)
Kynurenine Metabolites and Migraine: Experimental Studies and Therapeutic Perspectives
Annamaria Fejes et al.
CURRENT NEUROPHARMACOLOGY (2011)
Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity
Eran Tauber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
Denes Zadori et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease
Denes Zadori et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Migraine is a neuronal disease
J. Tajti et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery
Caroline M. Forrest et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment
Allison B. Gold et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Prevalence and Incidence Rates of Dementia and Cognitive Impairment No Dementia in the Mexican Population: Data From the Mexican Health and Aging Study
Silvia Mejia-Arango et al.
JOURNAL OF AGING AND HEALTH (2011)
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Costantino Iadecola
ACTA NEUROPATHOLOGICA (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains
Qian Han et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Kynurenate Derivative Attenuates the Nitroglycerin-Induced CamKIIα and CGRP Expression Changes
Eniko Vamos et al.
HEADACHE (2010)
Vascular Cognitive Disorder. A Biological and Clinical Overview
Leontino Battistin et al.
NEUROCHEMICAL RESEARCH (2010)
Glutamate receptors, neurotoxicity and neurodegeneration
Anthony Lau et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
Abdur Rahman et al.
PLOS ONE (2009)
Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease
Maria-Paz Marzolo et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
Cerebral amyloid angiopathy and its relationship to Alzheimer's disease
Dietmar Rudolf Thal et al.
ACTA NEUROPATHOLOGICA (2008)
Diagnosis and treatment of dementia: 2. Diagnosis
Howard H. Feldman et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate
Hermina Robotka et al.
LIFE SCIENCES (2008)
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus
Katalin Sas et al.
NEUROBIOLOGY OF DISEASE (2008)
The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus:: Comparative studies of the effects of SZR-72 and kynurenic acid
E. Knyihar-Csillik et al.
NEUROSCIENCE RESEARCH (2008)
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression
Trevor D. Burt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Altered kynurenine metabolism correlates with infarct volume in stroke
L. G. Darlington et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain
Paolo Guidetti et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils
Gabor Gigler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Elevations of endogenous kynurenic acid produce spatial working memory deficits
Amy C. Chess et al.
SCHIZOPHRENIA BULLETIN (2007)
Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease
Zsuzsanna Hartai et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family
P Yu et al.
GENE (2006)
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease
MT Sapko et al.
EXPERIMENTAL NEUROLOGY (2006)
Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites
A Bahn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus
GJ Guillemin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease
SARB Rombouts et al.
NEUROIMAGE (2005)
Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study
A Ruitenberg et al.
ANNALS OF NEUROLOGY (2005)
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
N Stoy et al.
JOURNAL OF NEUROCHEMISTRY (2005)
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease
F Giorgini et al.
NATURE GENETICS (2005)
The behavioural neurology assessment
S Darvesh et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2005)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Involvement of quinolinic acid in AIDS dementia complex
GJ Guillemin et al.
NEUROTOXICITY RESEARCH (2005)
Occurrence of cognitive impairment and dementia after the age of 60: A population based study from northern Italy
D De Ronchi et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia
E Kalbe et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
Advances in the early detection of Alzheimer's disease
PJ Nestor et al.
NATURE MEDICINE (2004)
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
P Guidetti et al.
NEUROBIOLOGY OF DISEASE (2004)
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review
CA Szekely et al.
NEUROEPIDEMIOLOGY (2004)
BACE1 - The beta-secretase enzyme in Alzheimer's disease
R Vassar
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy
M Valle et al.
BRAIN (2004)
Effect of 3-nitropropionic acid on kynurenine aminotransferase in the rat brain
A Csillik et al.
EXPERIMENTAL NEUROLOGY (2002)
The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
PS Aisen
LANCET NEUROLOGY (2002)
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
GJ Guillemin et al.
REDOX REPORT (2002)
Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum
E Lehrmann et al.
EXPERIMENTAL BRAIN RESEARCH (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Pathways to neuronal injury and apoptosis in HIV-associated dementia
M Kaul et al.
NATURE (2001)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Tryptophan degradation and immune activation in Alzheimer's disease
B Widner et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
